» Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne muscular dystrophy Action Duchenne: "Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne muscular dystrophy"
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment